Making Biospsies More Accurate

Dr. Joseph L. Chin (2003 Research Grant)

Physicians and patients have tough decisions to make when pre-cancerous lesions are found during biopsies because they have the potential to become cancerous and must be either removed or monitored. 

Surgically removing the whole prostate for the sake of a tiny pre-cancerous lesion is not ideal since prostatectomy has side effects and risks. However, pinpointing and monitoring tiny lesions is almost impossible using the standard techniques (needle biopsy guided by two-dimensional ultrasound imaging). 

Dr. Joseph Chin and his team are developing and testing state-of-the-art software that creates three-dimensional ultrasound images during biopsy. The new system will let doctors precisely locate lesions. Because the new software is compatible with current ultrasound machines and biopsy techniques, it will be cost-effective. Patient trials are not far off and the first publication on this experimental technology is in press.

 


Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive